R-NAT SCORE: A NOVEL TOOL TO PREDICT THROMBOSIS IN MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB (SIE 2026) - Oct 6, 2026 - Abstract #B04; Pres time: Sep 21, 2026; 10:25 AM - 11:40 AM; Location: PLENARY HALL; P | "The R-NAT Score may improve discrimina- tion of MF thrombotic risk compared with existing models. Baseline NLR and its dynamic evaluation are reliable bio- markers linking inflammatory control to thrombotic risk."
Clinical • Cardiovascular • Hematological Disorders • Inflammation • Myelofibrosis • Polycythemia Vera • Thrombocytosis • Thrombosis • JAK2
|
|
N. Severi1,2; F. Branzanti2; M. Breccia3; M. Bonifacio4; E. M. Elli5; E. Abruzzese6; M. Tiribelli7; E. Morsia8; M. Farina9; G. Benevolo10; E. Beggiato11; N. Pugliese12; A. Tieghi13; E. Scalzulli3; G. Binotto14; F. Cavazzini15; A. Iurlo16; M. Crugnola17; A. Duminuco18; O. Mulas19; A. Dedola1,2; F. Salvatore1,2; D. Cavallina1,2; D. Cattaneo16; F. Cavalca5; M. Trawinska6; B. Martino20; D. Cilloni21; M. Bocchia22; C. Bosi23; C. Fava24; F. Pane12; G. Caocci19; G. A. Palumbo25; C. Sartor1; F. Palandri1
|